Chardan Capital Initiates Coverage on Crispr Therapeutics AG … – Sports Perspectives
Petro Global News 24 |
Chardan Capital Initiates Coverage on Crispr Therapeutics AG …
Sports Perspectives Chardan Capital assumed coverage on shares of Crispr Therapeutics AG (NASDAQ:CRSP) in a report published on Monday morning. The brokerage issued a … Crispr Therapeutics AG (CRSP) Given Consensus Recommendation of "Strong Buy" by Analysts Stocks to Grab Market: CRISPR Therapeutics AG (NASDAQ:CRSP), Avino Silver & Gold Mines Ltd. (NYSE:ASM), Cisco … The Brokerages Set $25.83 Target Price for Crispr Therapeutics AG … |
